Bacteriologic Profile, Antibiotics Resistance Pattern, and Outcomes of Patients Admitted to Lancet General Hospital from June 2022 to June 2023: A Retrospective Cohort Study

Q3 Medicine
Zekewos Demissie, Serkalem Nurlegn, Nahom Zemedkun, Yidnekachew Demssis, Bethel Mekuriya, Eyob Beyene, Seifemichael Getachew, Desalew Mekonnen, Yohannes Birhanu, Brook Alemayehu, Nebiyat Sileshi, Gelila Sintayehu, D. Admasu, Kibruyisfaw Zewdie
{"title":"Bacteriologic Profile, Antibiotics Resistance Pattern, and Outcomes of Patients Admitted to Lancet General Hospital from June 2022 to June 2023: A Retrospective Cohort Study","authors":"Zekewos Demissie, Serkalem Nurlegn, Nahom Zemedkun, Yidnekachew Demssis, Bethel Mekuriya, Eyob Beyene, Seifemichael Getachew, Desalew Mekonnen, Yohannes Birhanu, Brook Alemayehu, Nebiyat Sileshi, Gelila Sintayehu, D. Admasu, Kibruyisfaw Zewdie","doi":"10.4314/emj.v62i1.3","DOIUrl":null,"url":null,"abstract":"Background: Prior studies indicated increased antimicrobial resistance in Ethiopia, with related health, economic, and environmental  costs. Knowing an institutions and population microbiologic profile allows for proper antibiotic treatment, which substantially impact  patients’ outcomes such as healthcare related costs, morbidity, and mortality. The current study assessed the bacteriologic profile,   resistance pattern, and treatment outcome in Lancet General Hospital. \nMethod: A retrospective cohort study on the bacteriologic profile, antibiotics resistance pattern, and outcome of patients was done on  128 eligible patients who were admitted to Lancet General Hospital from June 2022 to June 2023. Data from all hospitalized patients with  culture-confirmed infection were analyzed. SPSS version 26.0 was used to analyze the data. Association between independent and  dependent variables was analyzed using binary logistic regression model. \nResults: Gram-negative bacteria were recovered in 77% of the  cases. Extended-spectrum beta-lactamase producing Enterobacteriaceae was found in 37.5% (54) isolates and carbapenem resistant  bacteria were identified in 27.8% of patients. In-hospital mortality from multidrug resistant bacterial infection was 14.8%. Age ≥ 65 years, presence of septic shock, and presence of carbapenem-resistant bacteria were independently associated with increased in-hospital  mortality. \nConclusion: High number of resistant microorganisms was isolated, and increased mortality was documented from infections  caused by carbapenem-resistant bacteria. Multi-center studies should be done to determine the extent of resistant organisms in health  facilities throughout the country.epidemiology, and the findings should be factored into clinical decision making and program design for  disease prevention, screening, and treatment. It also calls for further prospective research to learn more about the conditions in the  context of additional relevant personal and clinical characteristics ","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ethiopian Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/emj.v62i1.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Prior studies indicated increased antimicrobial resistance in Ethiopia, with related health, economic, and environmental  costs. Knowing an institutions and population microbiologic profile allows for proper antibiotic treatment, which substantially impact  patients’ outcomes such as healthcare related costs, morbidity, and mortality. The current study assessed the bacteriologic profile,   resistance pattern, and treatment outcome in Lancet General Hospital. Method: A retrospective cohort study on the bacteriologic profile, antibiotics resistance pattern, and outcome of patients was done on  128 eligible patients who were admitted to Lancet General Hospital from June 2022 to June 2023. Data from all hospitalized patients with  culture-confirmed infection were analyzed. SPSS version 26.0 was used to analyze the data. Association between independent and  dependent variables was analyzed using binary logistic regression model. Results: Gram-negative bacteria were recovered in 77% of the  cases. Extended-spectrum beta-lactamase producing Enterobacteriaceae was found in 37.5% (54) isolates and carbapenem resistant  bacteria were identified in 27.8% of patients. In-hospital mortality from multidrug resistant bacterial infection was 14.8%. Age ≥ 65 years, presence of septic shock, and presence of carbapenem-resistant bacteria were independently associated with increased in-hospital  mortality. Conclusion: High number of resistant microorganisms was isolated, and increased mortality was documented from infections  caused by carbapenem-resistant bacteria. Multi-center studies should be done to determine the extent of resistant organisms in health  facilities throughout the country.epidemiology, and the findings should be factored into clinical decision making and program design for  disease prevention, screening, and treatment. It also calls for further prospective research to learn more about the conditions in the  context of additional relevant personal and clinical characteristics 
2022 年 6 月至 2023 年 6 月期间兰塞特综合医院住院患者的细菌学特征、抗生素耐药性模式和预后:回顾性队列研究
背景:先前的研究表明,埃塞俄比亚的抗菌药耐药性有所增加,并带来了相关的健康、经济和环境成本。了解机构和人群的微生物学概况有助于进行适当的抗生素治疗,这对患者的治疗效果(如医疗相关成本、发病率和死亡率)有重大影响。本研究评估了兰塞特综合医院的细菌学概况、耐药性模式和治疗效果。研究方法对 2022 年 6 月至 2023 年 6 月期间兰塞特综合医院收治的 128 名符合条件的患者的细菌学特征、抗生素耐药模式和治疗效果进行了回顾性队列研究。分析了所有经培养确诊感染的住院患者的数据。数据分析采用 SPSS 26.0 版。使用二元逻辑回归模型分析自变量和因变量之间的关系。结果77%的病例回收了革兰氏阴性菌。37.5%(54 例)的分离菌株中发现了产生广谱β-内酰胺酶的肠杆菌科细菌,27.8%的患者对碳青霉烯类耐药。耐多药细菌感染的院内死亡率为 14.8%。年龄≥65岁、出现脓毒性休克和耐碳青霉烯类细菌与院内死亡率升高密切相关。结论大量耐药微生物被分离出来,耐碳青霉烯类细菌引起的感染导致死亡率升高。应开展多中心研究,以确定全国各地医疗机构中耐药微生物的程度和流行病学,并将研究结果纳入临床决策和疾病预防、筛查和治疗的方案设计中。该报告还呼吁进一步开展前瞻性研究,以便结合更多相关的个人和临床特征了解更多情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ethiopian Medical Journal
Ethiopian Medical Journal Medicine-Medicine (all)
CiteScore
0.40
自引率
0.00%
发文量
0
期刊介绍: The Ethiopian Medical Journal (EMJ) is the official Journal of the Ethiopian Medical Association (EMA) and devoted to the advancement and dissemination of knowledge pertaining to the broad field of medicine in Ethiopia and other developing countries. Prospective contributors to the Journal should take note of the instructions of Manuscript preparation and submission to EMJ as outlined below.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信